Development

Development history:

The company was established on June 1, 2010

On January 3, 2011, the development and production of infectious disease series antigen and antibody began

On June 1, 2012, the development and production of secondary antibody and protein hormone antigen antibody began

On January 3, 2013, the development and production of tumor series antigen and antibody began

On January 3, 2015, drug series antigen and antibody began to develop and produce

On October 1, 2015, it officially entered the foreign market.

Perfect and optimize the production of antigen and antibody since 2016.

On January 3, 2020, the Nitrocellulose membrane r&d and production team was established